← Evidence map

ArticleJournal of thoracic disease2026

Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study.

Rosen E Petkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study. | OpenQuestion